LifeVantage stock reports 22% revenue drop in fiscal Q1
Published on 11/17/2026 at 01:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSLifeVantage resets after weak quarter
- The company posted a net loss after profit in the year-earlier quarter.
- Management plans a more digital brand and selling model in 2027.
- The board approved a quarterly cash dividend payable in December.
LifeVantage reported a sharp deterioration in its fiscal first quarter on November 9, as lower active accounts and weaker sales of the MindBody GLP-1 System weighed on revenue. The company said it is repositioning the brand and rebuilding its digital sales infrastructure as it seeks to stabilize the business.
According to the company's earnings release, revenue for the quarter ended September 30 was USD 37.1 million, down 22.0 percent from USD 47.6 million a year earlier. LifeVantage recorded a net loss of USD 0.2 million, or USD 0.02 per diluted share, compared with net income of USD 2.2 million, or USD 0.17 per diluted share.
Margins and accounts remain under pressure
Adjusted earnings per diluted share were USD 0.05, versus USD 0.18 in the prior-year quarter. Adjusted EBITDA fell to USD 1.9 million from USD 3.9 million, while adjusted EBITDA margin declined to 5.2 percent from 8.2 percent.
Gross margin fell to 75.4 percent from 79.5 percent. LifeVantage attributed the change partly to a USD 1.045 million allowance for inventory obsolescence tied to its MindBody GLP-1 System, as well as higher shipping and warehouse expenses. Total active accounts declined to 98,000 from 121,000, including 58,000 active customers and 40,000 active independent consultants.
Management targets a digital rebuild
Chief Executive Officer Terrence Moorehead said the company is simplifying its selling proposition and strengthening customer acquisition, retention and referrals. LifeVantage plans a new North American website and digital platform in the second quarter of calendar 2027, followed by a business suite for sellers in the third quarter. The company did not provide formal financial guidance and will align its fiscal year with the calendar year from January 1, 2027.
The board also approved a quarterly cash dividend of USD 0.05 per share on November 9. Payment is scheduled for December 15 to shareholders of record on December 1.
LifeVantage business profile
LifeVantage develops nutrigenomics-based wellness products, including Protandim, TrueScience Liquid Collagen, the MindBody GLP-1 System, AXIO energy mixes and Petandim supplements. Independent consultants sell the products to customers and entrepreneurs across the Americas and the Asia-Pacific and Europe region. The company was founded in 2003 and is headquartered in Lehi, Utah.
LifeVantage key facts
- Company: LifeVantage Corporation
- ISIN: US53222K2050
- Ticker: LFVN
- Exchange: Nasdaq
- Headquarters: Lehi, Utah, United States
- Fiscal quarter: Quarter ended September 30, 2026
LifeVantage operates within the US market environment tracked by the S&P 500.
